Search

everythinglearnresearchcommunity

for

Search:↓

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Phoenixin levels are higher in PCOS patients and may help in diagnosis.

DHEA therapy improves pubic hair growth and psychological well-being in girls with central adrenal insufficiency.

The medicine Diane is effective in treating hair loss, severe acne, and excessive hair growth.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

Birth control pills with cyproterone acetate and drosperinone can reduce excessive hair growth in women with PCOS, but they may not be right for everyone.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Finasteride-loaded microemulsions, made with cinnamon oil, Tween20, propylene glycol, and water, can help maintain stemness of dermal cells, potentially aiding in hair regeneration.

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

DPCP is effective for treating severe alopecia areata, but relapse is common.

A rare adrenal tumor in a woman only made DHEA-S, causing hair thinning, and was removed, fixing the hormone level.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Topical DHEA safely increases skin oil production.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Finasteride forms three new products under acidic stress.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

The new nanocarriers improve how well water-insoluble drugs dissolve and allow for controlled drug release.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Diphlorethohydroxycarmalol may help treat hair loss better than current medications.

Finasteride, a drug, can block the seizure-preventing effects of a hormone called progesterone in mice.

Progesterone reduces spinal reflex activity by increasing certain GABA(A) receptor subtypes.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

The inhibitor DPP can promote hair growth.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

PPCM microspheres allow controlled finasteride release over 24 hours.